IBX vs PHX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IBX

IMAGIONBIO FPO [IBX]

28LOW

PHX

PHARMX FPO [PHX]

42LOW

Score Breakdown

IBX PHX
Technical
35
57
Catalyst
53
51
Sentiment
50
50
Fundamental
17
66
Momentum
25
55
Risk Gate
27
50

Key Metrics

IBX Metric PHX
$6.5MMarket Cap$79.1M
2.6MAvg Volume (20d)448K
N/AShort InterestN/A
$0.05552-Week High$0.200
$0.01152-Week Low$0.084
+0.0%Daily Change+0.0%
$0.011Reference Price$0.120
N/AROE-5.9%
N/AProfit Margin-12.2%

Active Signals

IBX Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Above-average volume (1.8x) on a red day — sellers in control
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Sitting near support — this level has held before and could attract buyers again
Took a hit — down 15.4% over the last 5 days

PHX Signals

Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Moderate P/S ratio (10.3x)
Small-cap ($20-100M)
Capital raise activity (1 events)
CANSLIM S: Tight float (41%)
Negative profit margins (-12%)

Ask Scout AI to compare IBX and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IBX vs PYC →IBX vs RCE →IBX vs RHY →IBX vs TRI →IBX vs TRU →
IBX Full Analysis → PHX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).